Table 3.

HCC surveillance practice patterns in post-SVR patients (n=279)

Provider practice	N (%)
Length of time cirrhosis patients with SVR post-DAAs are followed in hepatology clinic
Indefinitely	255 (91.7)
Approx. 1 year then discharge to PCP	9 (3.2)
Approx. 3–5 years then discharge to PCP	6 (2.2)
Not routinely followed; seen as needed	9 (2.9)
Method of HCC surveillance in cirrhosis patients after SVR
Imaging (US, CT, or MR) +/− AFP every 6 months indefinitely	264 (95.0)
Imaging (US, CT, or MR) +/− AFP every 12 months indefinitely	8 (2.9)
Imaging (US, CT, or MR) +/− AFP every 6 months, stop after few years	2 (0.7)
Other	4 (1.4)
Do you perform HCC surveillance in patients with F3 fibrosis after SVR?
Yes	169 (61.0)
Sometimes	91 (32.9)
No	17 (6.1)

HCC – hepatocellular carcinoma; SVR – sustained virologic response; DAA – direct-acting antivirals; US – ultrasound; CT – computed tomography; MR – magnetic resonance imaging; F3 – stage 3 fibrosis